Releases
Found 35204 articles
BOE Brings IPC Innovation Forum to Berlin for European Expansion
Stepping onto the global stage during IFA 2026, Chinese display giant BOE hosted its first overseas Innovation Partner Conference in Berlin on September 7. The event gathered over 200 international partners to pivot toward the European market, anchoring its strategy in a new proprietary framework dubbed LIGHT.
Fujitsu Unveils Diamond-Spin Quantum Prototype
Operating at temperatures significantly higher than traditional superconducting models, Fujitsu’s new diamond-spin quantum computer prototype integrates tin-vacancy centers into photonic circuits. Developed alongside Delft University of Technology and QuTech, the system represents a strategic move toward modular architectures capable of scaling to 1,000 logical qubits by 2035.
Implantica readies U.S. market launch for RefluxStop
With FDA approval for its RefluxStop device now in hand, Implantica AG is turning its focus toward the American market, where an estimated 78 million people suffer from acid reflux. The company will outline its commercial rollout strategy during a Capital Markets Day gathering in Stockholm on September 9.
Implantica Sets Sights on U.S. Market Following RefluxStop Approval
With FDA approval of its flagship RefluxStop device now secured, Implantica AG is turning its attention to a massive U.S. market segment where an estimated 78 million people suffer from chronic acid reflux. The company will outline its commercial rollout strategy during a Capital Markets Day in Stockholm on September 9.
BIGBANG to Perform Three-Night Residency at Hong Kong’s Kai Tak Stadium
The legendary boy group BIGBANG is set to bring their 2026-2027 world tour, titled , to Hong Kong this November. The three-night residency at the newly minted Kai Tak Stadium marks a high-profile return to the city for the group, which celebrates its 20th anniversary this year.
Investors Target ARS Pharmaceuticals Over Alleged Disclosure Failures
A class action lawsuit filed against ARS Pharmaceuticals claims the company misled shareholders regarding the commercialization timeline for its neffy product. Investors who purchased stock between March 9 and June 24, 2026, are now evaluating claims that the company concealed critical delays in CVS Caremark formulary coverage approvals.
Investors Target Blaize Holdings Over Alleged Misleading Growth Claims
A class action lawsuit now challenges Blaize Holdings, Inc. regarding claims that the company manufactured an illusion of growth by securing agreements with entities incapable of honoring them. Shareholders who acquired BZAI stock between July 18, 2025, and April 28, 2026, are currently evaluating potential legal recourse for financial losses.
Investors Urged to Join Securities Class Action Against ARS Pharmaceuticals
Shareholders who held ARS Pharmaceuticals stock between March 9 and June 24, 2026, face an October 5 deadline to participate in a class action lawsuit. Los Angeles-based firm Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs to address allegations of securities fraud involving misleading commercial guidance.
Capricor Therapeutics Faces Class Action Over Deramiocel Clinical Data
Investors who purchased Capricor Therapeutics shares between December 17, 2025, and July 26, 2026, are being urged to join a securities class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on misleading public statements regarding the development of the drug Deramiocel.
Rackspace Technology Faces Securities Fraud Class Action Lawsuit
Investors who purchased Rackspace Technology shares between May 7 and July 8, 2026, are facing a September 28 deadline to join a class action lawsuit. The litigation, led by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding its financial stability and strategic pivot toward enterprise AI.
Shenzhen’s i2Cool Secures Series B Funding to Scale Radiative Cooling
Shenzhen-based material science firm i2Cool has secured tens of millions of yuan in Series B funding led by TopoScend Capital. The company, which specializes in electricity-free passive radiative cooling technology, plans to use the capital to automate nanoparticle production lines and accelerate its expansion into global markets.
Capricor Therapeutics Faces Securities Class Action Over Deramiocel Data
Investors who purchased Capricor Therapeutics stock between December 17, 2025, and July 26, 2026, face a September 28 deadline to join a class action lawsuit. Schall, Brown & Schwartz LLP is representing shareholders alleging the company misled the market regarding regulatory protocols for its drug, Deramiocel.
DJS Law Group Files Securities Class Action Against DNOW Inc.
Investors who held DNOW shares as of August 5, 2025, are being recruited for a class action lawsuit alleging the company misled the market. The litigation centers on claims that DNOW downplayed integration failures linked to its merger with MRC Global Inc. and its enterprise resource planning software implementation.
Pentair Faces Class Action Lawsuit Over Alleged Securities Violations
Investors who purchased Pentair plc shares between April 28, 2026, and July 14, 2026, are being urged to join a class action lawsuit. The litigation alleges the company issued false and misleading statements regarding the impact of destocking in its Pool channel, concealing financial performance issues from the market.
Pentair Investors Face October Deadline in Securities Fraud Class Action
Investors who purchased Pentair plc shares between April 28 and July 14, 2026, face an October 2 deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation alleges that the company misled shareholders regarding the financial impact of significant destocking within its Pool channel.
Investors Eye Lead Plaintiff Role in Blaize Holdings Securities Suit
Investors who purchased Blaize Holdings, Inc. stock between July 18, 2025, and April 28, 2026, face an October 5, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act of 1934 regarding the company's financial reporting.
Datavault AI Faces Securities Fraud Class Action Over Inflated Metrics
Investors who purchased Datavault AI Inc. stock between September 4, 2024, and October 30, 2025, are being recruited for a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, claiming the company misled shareholders regarding the actual performance and trading volume of its platform.
Main Capital Partners Acquires Majority Stake in Workforce Software Orgvue
Main Capital Partners has officially entered the UK market, acquiring a majority stake in Orgvue, a London-based specialist in Strategic Workforce Management software. The investment aims to accelerate the firm's international expansion and product development as global enterprises increasingly prioritize complex workforce modeling and optimization.
Rockwell Automation Targets Industrial Cyber Resilience in ROKStudios
Nearly half of global manufacturers faced a cyber incident last year, prompting Rockwell Automation to launch a new season of its ROKStudios video series. Filmed at the Secure Digital Operations Forum in the UK, the episodes focus on shifting industrial security from a compliance checklist to a core business strategy.
Flysound Launches B02 Open-Fit AI Hearing Aid in U.S. Market
A significant portion of the population struggles with traditional in-ear hearing devices due to anatomical constraints or physical discomfort. Addressing this gap, Flysound has introduced its B02 Open-Fit AI Hearing Aid to the U.S. market, utilizing an ear-clip design that bypasses the ear canal entirely.
Autoliv Launches Human Body Model Suite for Virtual Crash Testing
Toyota has become the first automaker to adopt Autoliv’s new Human Body Model Safety Suite, a platform designed to simulate complex crash scenarios. By shifting from physical dummies to detailed digital anatomy, the system aims to provide deeper insights into injury mechanisms while accelerating vehicle development cycles.
Rackspace Faces Class Action Lawsuit Over Alleged Securities Violations
Investors who purchased Rackspace Technology shares between May 7 and July 8, 2026, are being urged to join a class action lawsuit. The legal action alleges that the company misled shareholders by obscuring the true state of its business operations while aggressively pivoting toward artificial intelligence investments.
Investors Urged to Join Securities Fraud Lawsuit Against Wise Group plc
Shareholders who purchased Wise Group plc stock between May 11 and July 23, 2026, face a September 28 deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged violations of federal securities laws stemming from the company's failure to maintain adequate anti-money laundering controls.
LX Pantos Delivers French-Made Missiles for Korean Marine Helicopters
A specialized charter flight carrying air-to-air missiles arrived at Incheon International Airport from France this week, marking the completion of a high-security defense logistics mission. The cargo, destined for the Republic of Korea Marine Corps' attack helicopter program, required complex international clearance across 14 separate nations.
Investors Target EquipmentShare Over Securities Fraud Allegations
Investors who purchased EquipmentShare.com Inc. stock between January 23 and June 23, 2026, face a looming September 21 deadline to join a class action lawsuit. The litigation centers on claims that the company misled the market by failing to disclose persistent related-party transactions during the specified period.
GCCL Expands Clinical Trial Services Across Asia-Pacific
With 650 industry professionals gathering in Singapore for the Asia Bio Partnering Forum 2026, South Korea’s GCCL leveraged its position as a Platinum Sponsor to deepen ties with global drug developers and expand its reach in the clinical trial sample analysis sector across the Asia-Pacific region.
Investors File Class Action Lawsuit Against Wix.com Over AI Claims
Shareholders who purchased Wix.com stock between February 19, 2025, and May 12, 2026, face a critical September 22 deadline to join a class action lawsuit. The litigation alleges that the company misled the market regarding the actual development costs and competitive viability of its proprietary AI tools.
Investors File Securities Class Action Against PROCEPT BioRobotics
Investors who held PROCEPT BioRobotics shares between February 28, 2024, and February 25, 2026, face a critical deadline to join a class action lawsuit. The DJS Law Group is currently organizing plaintiffs following allegations that the company misled shareholders regarding its revenue reporting and inventory management practices.
Bloom Energy Faces Securities Fraud Class Action Over Supply Chain Claims
Investors who purchased Bloom Energy Corporation shares between February 27, 2025, and July 8, 2026, are being urged to join a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the true origin of its scandium supply chain.
Wix Faces Securities Class Action Over AI Product Misrepresentations
Investors who purchased Wix.com Ltd. stock between February 19, 2025, and May 12, 2026, face a September 22, 2026, deadline to seek lead plaintiff status in a class action lawsuit. The litigation claims the company misled shareholders regarding the competitiveness and development costs of its AI-driven platforms.